GE Healthcare will pay SonoSite $21 million for a perpetual nontransferable worldwide license to a family of ultrasound patents addressing hand-carried ultrasound scanners, according to the Bothell, WA-based developer of these systems.
GE settles SonoSite lawsuits
GE Healthcare will pay SonoSite $21 million for a perpetual nontransferable worldwide license to a family of ultrasound patents addressing hand-carried ultrasound scanners, according to the Bothell, WA-based developer of these systems. In addition to the upfront payment, GE will pay ongoing royalties on U.S. sales and production of ultrasound systems weighing less than ten pounds until 2016, when the relevant patents expire. Specifically, the agreement, announced Oct. 19, resolves a lawsuit filed in 2008 by GE in the federal district court in Madison, WI, to invalidate SonoSite's US Patent No. 5,722,412. It also covers pending appeals of certain rulings in a patent infringement case filed by GE in the same Wisconsin court in 2007. The settlement further resolves a revocation action filed by GE in Federal Patent Court in Germany relating to the '412 patent.
Philips Launches Flash 5100 Point-of-Care Ultrasound System
June 17th 2025Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.